Mirtazapine efficacious in antipsychotic-induced akathisia

被引：0

作者：

机构：

来源：

Reactions Weekly | 2003年 / 966卷 / 1期

关键词：

Public Health; Placebo; Pilot Study; Placebo Group; Complete Resolution;

D O I：

10.2165/00128415-200309660-00008

中图分类号：

学科分类号：

摘要：

引用

页码：4 / 4

共 34 条

[21] Cocaine use is a major risk factor for the development of antipsychotic-induced acute dystonia
Reactions Weekly, 1998, 698 (1) : 4 - 4
[22] Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
Takeshima, Masahiro
Ishikawa, Hiroyasu
Kanbayashi, Takashi
Shimizu, Tetsuo
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 3179 - 3184
[23] Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials
Lockwood, Jonathan Tomas
Remington, Gary
EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (03) : 407 - 421
[24] Mirtazapine reduces levodopa-induced dyskinesia
Reactions Weekly, 2003, 968 (1) : 4 - 4
[25] More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial
Terevnikov, Viacheslav
Stenberg, Jan-Henry
Joffe, Marina
Tiihonen, Jari
Burkin, Mark
Tchoukhine, Evgueni
Joffe, Grigori
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (06) : 431 - 438
[26] Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study
Chen, Ying Qi
Li, Xi Rong
Zhang, Lie
Zhu, Wei Bo
Wu, Ya Qing
Guan, Xiao Ni
Xiu, Mei Hong
Zhang, Xiang Yang
JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (03)
[27] ACP 103 reduces haloperidol-induced akathisia and hyperprolactinaemia
Reactions Weekly, 2004, 1020 (1) : 4 - 4
[28] ACP-103 shows promise in haloperidol-induced akathisia
Reactions Weekly, 2006, 1084 (1) : 4 - 4
[29] Quetiapine as efficacious as clozapine in antiparkinsonian-induced psychosis
Reactions Weekly, 2004, 1020 (1) : 4 - 4
[30] Lipid Abnormalities Induced by Novel Antipsychotic Drugs
Drug Safety, 2001, 24 : 1017 - 1018

← 1 2 3 4 →